Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- LaNova Australia Pty Limited
- Target Recruit Count
- 60
- Registration Number
- NCT05199753
- Locations
- 🇦🇺
Blacktown Hospital, Sydney, New South Wales, Australia
🇦🇺Sunshine Coast University Private Hospital, Birtinya, Queensland, Australia
🇦🇺ICON Cancer Centre, South Brisbane, Queensland, Australia
Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2025-02-17
- Lead Sponsor
- LaNova Australia Pty Limited
- Target Recruit Count
- 20
- Registration Number
- NCT05188664
- Locations
- 🇦🇺
The Alfred, Melbourne, Australia
News
No news found